Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oruka Therapeutics Price to Free Cash Flow Ratio 2010-2024 | ORKA

Historical price to free cash flow ratio values for Oruka Therapeutics (ORKA) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Oruka Therapeutics Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-10-31 28.00 0.00
2024-06-30 27.94 $-5.71 0.00
2024-03-31 12.84 $-4.11 0.00
2023-12-31 12.40 $-4.18 0.00
2023-09-30 14.66 $-4.54 0.00
2023-06-30 14.81 $-5.23 0.00
2023-03-31 14.52 $-6.84 0.00
2022-12-31 17.29 $-9.09 0.00
2022-09-30 15.03 $-12.55 0.00
2022-06-30 18.16 $-14.53 0.00
2022-03-31 16.78 $-14.74 0.00
2021-12-31 15.68 $-16.24 0.00
2021-09-30 21.59 $-21.87 0.00
2021-06-30 25.46 $-8.91 0.00
2021-03-31 26.62 $-12.10 0.00
2020-12-31 29.25 $-19.74 0.00
2020-09-30 32.24 $-24.30 0.00
2020-06-30 48.29 $-35.79 0.00
2020-03-31 20.35 $-35.40 0.00
2019-12-31 41.65 $-43.67 0.00
2019-09-30 39.02 $-50.43 0.00
2019-06-30 53.39 $-72.33 0.00
2019-03-31 49.05 $-101.00 0.00
2018-12-31 43.79 $-128.76 0.00
2018-09-30 73.52 $-219.58 0.00
2018-06-30 73.00 $-228.89 0.00
2018-03-31 65.57 $-307.32 0.00
2017-12-31 177.24 $-361.72 0.00
2017-09-30 150.98 $-340.85 0.00
2017-06-30 315.10 $-396.11 0.00
2017-03-31 334.79 $-367.68 0.00
2016-12-31 374.18 $-357.17 0.00
2016-09-30 371.55 $-438.23 0.00
2016-06-30 380.74 $-237.00 0.00
2016-03-31 455.58 $-232.25 0.00
2015-12-31 610.50 $-362.03 0.00
2015-09-30 651.20 $-342.53 0.00
2015-06-30 1056.89 $-603.76 0.00
2015-03-31 726.13 $-620.39 0.00
2014-12-31 876.39 $-694.53 0.00
2014-09-30 1139.61 $-992.55 0.00
2014-06-30 1341.79 $-786.87 0.00
2014-03-31 1709.41 $-843.26 0.00
2013-12-31 1543.98 $-931.53 0.00
2013-09-30 1470.46 $-480.70 0.00
2013-06-30 1185.56 $-537.49 0.00
2013-03-31 2187.31 $-385.85 0.00
2012-12-31 2095.40 $-1.84 0.00
2012-09-30 1909.02 $-5.11 0.00
2012-06-30 2646.83 $-5.07 0.00
2012-03-31 5017.94 $-4.76 0.00
2011-12-31 5514.22 $-4.16 0.00
2011-09-30 6175.93 $-0.71 0.00
2011-06-30 8877.90 $-0.78 0.00
2011-03-31 14061.27 $-0.79 0.00
2010-12-31 17480.09 $-0.98 0.00
2010-09-30 21009.19 $-1.57 0.00
2010-06-30 18913.78 $-2.72 0.00
2010-03-31 30052.51 $-3.82 0.00
2009-12-31 17976.37 $-5.87 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.033B $0.000B
Oruka Therapeutics Inc. is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka Therapeutics Inc., formerly known as ARCA biopharma Inc., is based in WESTMINSTER, Colo.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $82.433B 32.84
Takeda Pharmaceutical (TAK) Japan $44.419B 9.25
Astellas Pharma (ALPMY) Japan $21.101B 19.43
Sandoz Group AG (SDZNY) Switzerland $19.843B 0.00
United Therapeutics (UTHR) United States $16.698B 16.43
Summit Therapeutics (SMMT) United States $14.004B 0.00
Shionogi (SGIOY) Japan $12.722B 12.19
Neurocrine Biosciences (NBIX) United States $12.373B 32.76
Catalent (CTLT) United States $10.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.939B 0.00
Orion OYJ (ORINY) Finland $6.848B 19.25
Jazz Pharmaceuticals (JAZZ) Ireland $6.821B 7.23
Ionis Pharmaceuticals (IONS) United States $5.667B 0.00
Corcept Therapeutics (CORT) United States $4.989B 37.79
Crinetics Pharmaceuticals (CRNX) United States $4.537B 0.00
PTC Therapeutics (PTCT) United States $3.113B 0.00
Dyne Therapeutics (DYN) United States $2.886B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.628B 15.16
Catalyst Pharmaceuticals (CPRX) United States $2.598B 20.65
Arrowhead Pharmaceuticals (ARWR) United States $2.423B 0.00
Soleno Therapeutics (SLNO) United States $2.171B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.799B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.776B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.744B 0.00
Ocular Therapeutix (OCUL) United States $1.620B 0.00
Harrow (HROW) United States $1.619B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.604B 0.00
Xencor (XNCR) United States $1.487B 0.00
ARS Pharmaceuticals (SPRY) United States $1.479B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.449B 0.00
Ardelyx (ARDX) United States $1.434B 0.00
Evotec AG (EVO) Germany $1.375B 0.00
Enliven Therapeutics (ELVN) United States $1.305B 0.00
Indivior (INDV) United States $1.289B 5.25
Cassava Sciences (SAVA) United States $1.257B 0.00
Guardian Pharmacy Services (GRDN) United States $1.134B 0.00
Bioventus (BVS) United States $1.100B 35.74
Collegium Pharmaceutical (COLL) United States $1.078B 6.18
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.047B 0.00
Cronos Group (CRON) Canada $0.826B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
USANA Health Sciences (USNA) United States $0.710B 13.18
Tourmaline Bio (TRML) United States $0.674B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.669B 41.90
Savara (SVRA) United States $0.593B 0.00
Exscientia (EXAI) United Kingdom $0.592B 0.00
Korro Bio (KRRO) United States $0.541B 0.00
Elite Pharmaceuticals (ELTP) United States $0.536B 50.14
Silence Therapeutics (SLN) United Kingdom $0.529B 0.00
Siga Technologies (SIGA) United States $0.515B 6.16
Aquestive Therapeutics (AQST) United States $0.503B 0.00
Verve Therapeutics (VERV) United States $0.502B 0.00
OmniAb (OABI) United States $0.494B 0.00
Larimar Therapeutics (LRMR) United States $0.494B 0.00
Xeris Biopharma Holdings (XERS) United States $0.481B 0.00
Altimmune (ALT) United States $0.479B 0.00
KalVista Pharmaceuticals (KALV) United States $0.459B 0.00
ProKidney (PROK) United States $0.449B 0.00
Zevra Therapeutics (ZVRA) United States $0.442B 0.00
4D Molecular Therapeutics (FDMT) United States $0.421B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Esperion Therapeutics (ESPR) United States $0.398B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.384B 0.00
Sage Therapeutics (SAGE) United States $0.370B 0.00
Organogenesis (ORGO) United States $0.369B 0.00
Akebia Therapeutics (AKBA) United States $0.355B 0.00
Aldeyra Therapeutics (ALDX) United States $0.319B 0.00
Lyell Immunopharma (LYEL) United States $0.287B 0.00
Heron Therapeutics (HRTX) United States $0.270B 0.00
Avita Medical (RCEL) United States $0.268B 0.00
Lexeo Therapeutics (LXEO) United States $0.262B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.250B 0.00
Acrivon Therapeutics (ACRV) United States $0.248B 0.00
Nature's Sunshine Products (NATR) United States $0.243B 16.59
Enanta Pharmaceuticals (ENTA) United States $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.226B 0.00
Pyxis Oncology (PYXS) United States $0.223B 0.00
Nanobiotix S.A (NBTX) France $0.207B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.204B 0.00
MediWound (MDWD) Israel $0.198B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Context Therapeutics (CNTX) United States $0.170B 0.00
Incannex Healthcare (IXHL) Australia $0.164B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.156B 0.00
CytoDyn (CYDY) United States $0.155B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
Aclaris Therapeutics (ACRS) United States $0.149B 0.00
VAXART, INC (VXRT) United States $0.137B 0.00
Fractyl Health (GUTS) United States $0.136B 0.00
Journey Medical (DERM) United States $0.128B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.113B 0.00
AlloVir (ALVR) United States $0.110B 0.00
Century Therapeutics (IPSC) United States $0.107B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
OptiNose (OPTN) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.098B 17.17
Regulus Therapeutics (RGLS) United States $0.098B 0.00
CASI Pharmaceuticals (CASI) China $0.093B 0.00
Arch Biopartners (ACHFF) Canada $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.084B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
ElectroCore (ECOR) United States $0.074B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.068B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Citius Pharmaceuticals (CTXR) United States $0.065B 0.00
ESSA Pharma (EPIX) Canada $0.062B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Champions Oncology (CSBR) United States $0.054B 0.00
Protara Therapeutics (TARA) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.051B 0.00
Unicycive Therapeutics (UNCY) United States $0.047B 0.00
Inotiv (NOTV) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
Surrozen (SRZN) United States $0.042B 0.00
DURECT (DRRX) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
ProPhase Labs (PRPH) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
BioLineRx (BLRX) Israel $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
Lipocine (LPCN) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.028B 0.00
BioVie (BIVI) United States $0.026B 0.00
GlycoMimetics (GLYC) United States $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
MEI Pharma (MEIP) United States $0.020B 0.71
Inhibikase Therapeutics (IKT) United States $0.020B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
CERo Therapeutics Holdings (CERO) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.43
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.28